Trending Now
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Presents Positive Results Of Phase...
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has given an oral presentation of encouraging results from the Phase 3 clinical study, RELIEF evaluating its TNX-102...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Will Kazia Therapeutics Limited (KZIA) Keep Surging based on a New...
A Glimpse at Today's Market Activity
Before diving into the recent medical breakthroughs, let's take a quick look...
MAKE IT MODERN
LATEST REVIEWS
Sorrento Therapeutics Inc. (NASDAQ: SRNE) Receives CE mark And Marketing Approval...
Sorrento Therapeutics Inc. (NASDAQ: SRNE) has received an official CE Mark for COVISTIX and marketing approval from Federal Agency for Medicines and Health Products...
MAKE IT MODERN
PERFORMANCE TRAINING
Akebia Therapeutics Inc. (NASDAQ: AKBA) Amends and Restates Terms of Agreement With Vifor Pharma...
Akebia Therapeutics Inc. (NASDAQ: AKBA) has announced the amendment and restated terms of its license agreement with Vifor Pharma Group. According to the amendment,...
Moleculin Biotech Inc. (NASDAQ:MBRX) Enters Into an Agreement with Sterling Pharma USA LLC to...
Since its inception, Moleculin Biotech, Inc., has been scaling its operations in the development of treatment of highly resistant tumors and viruses. The company...
Super Micro Computer’s Q4 Outlook ($SMCI) Boosts Investor Confidence Despite Q3 Miss
Super Micro Computer, a leading server technology firm, has seen its price target hiked after reporting its latest quarterly results. Despite missing...
VistaGen Therapeutics (NASDAQ:VTGN) Sign Agreement With Nuformix To Develop AV-101 cocrystalline Formulation For Various...
VistaGen Therapeutics (NASDAQ:VTGN) has announced an agreement with Nuformix Plc to develop a cocrystalline formulation of AV-101 based ion VistaGen's CNS products for the...
Churchill Capital Corp IV (NYSE:CCIV) Issues Statement
Update: CCIV shares are trading higher following a report that Lucid Motors is in talks with Saudi Arabia's sovereign wealth fund to...
MAKE IT MODERN
